patrick c walsh
patrick c walsh
Professor of Urology Johns Hopkins University
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Natural history of progression after PSA elevation following radical prostatectomy
CR Pound, AW Partin, MA Eisenberger, DW Chan, JD Pearson, PC Walsh
Jama 281 (17), 1591-1597, 1999
32861999
The development of human benign prostatic hyperplasia with age
SJ Berry, DS Coffey, PC Walsh, LL Ewing
The Journal of urology 132 (3), 474-479, 1984
29041984
Longitudinal effects of aging on serum total and free testosterone levels in healthy men
SM Harman, EJ Metter, JD Tobin, J Pearson, MR Blackman
The Journal of Clinical Endocrinology & Metabolism 86 (2), 724-731, 2001
24102001
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update
AW Partin, MW Kattan, ENP Subong, PC Walsh, KJ Wojno, JE Oesterling, ...
Jama 277 (18), 1445-1451, 1997
23151997
Impotence following radical prostatectomy: insight into etiology and prevention
PC Walsh, PJ Donker
The Journal of urology 128 (3), 492-497, 1982
20581982
Pathologic and clinical findings to predict tumor extent of nonpalpable (stage t1 c) prostate cancer
JI Epstein, PC Walsh, M Carmichael, CB Brendler
Jama 271 (5), 368-374, 1994
19741994
Campbell-Walsh urology: expert consult premium edition: enhanced online features and print, 4-volume set
AJ Wein, LR Kavoussi, AC Novick, AW Partin, CA Peters
Elsevier Health Sciences, 2011
17502011
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
AW Partin, J Yoo, HB Carter, JD Pearson, DW Chan, JI Epstein, PC Walsh
The Journal of urology 150 (1), 110-114, 1993
15051993
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial
WJ Catalona, AW Partin, KM Slawin, MK Brawer, RC Flanigan, A Patel, ...
Jama 279 (19), 1542-1547, 1998
14811998
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
HB Carter, JD Pearson, EJ Metter, LJ Brant, DW Chan, R Andres, ...
Jama 267 (16), 2215-2220, 1992
14441992
Risk of prostate cancer–specific mortality following biochemical recurrence after radical prostatectomy
SJ Freedland, EB Humphreys, LA Mangold, M Eisenberger, FJ Dorey, ...
Jama 294 (4), 433-439, 2005
13192005
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium
AW Partin, LA Mangold, DM Lamm, PC Walsh, JI Epstein, JD Pearson
Urology 58 (6), 843-848, 2001
13172001
Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer
J Li, Z Zhang, J Rosenzweig, YY Wang, DW Chan
Clinical chemistry 48 (8), 1296-1304, 2002
12852002
The effect of finasteride in men with benign prostatic hyperplasia
GJ Gormley, E Stoner, RC Bruskewitz, J Imperato-McGinley, PC Walsh, ...
New England Journal of Medicine 327 (17), 1185-1191, 1992
12531992
Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations
PC Walsh, H Lepor, JC Eggleston
The Prostate 4 (5), 473-485, 1983
11961983
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience
M Han, AW Partin, CR Pound, JI Epstein, PC Walsh
Urologic Clinics of North America 28 (3), 555-565, 2001
11952001
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Z Zhang, RC Bast, Y Yu, J Li, LJ Sokoll, AJ Rai, JM Rosenzweig, ...
Cancer research 64 (16), 5882-5890, 2004
11772004
Family history and the risk of prostate cancer
GD Steinberg, BS Carter, TH Beaty, B Childs, PC Walsh
The prostate 17 (4), 337-347, 1990
10311990
Mendelian inheritance of familial prostate cancer.
BS Carter, TH Beaty, GD Steinberg, B Childs, PC Walsh
Proceedings of the National Academy of Sciences 89 (8), 3367-3371, 1992
10301992
Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer
R Hu, TA Dunn, S Wei, S Isharwal, RW Veltri, E Humphreys, M Han, ...
Cancer research 69 (1), 16-22, 2009
9722009
The system can't perform the operation now. Try again later.
Articles 1–20